Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial

Concerns about inadequate performance and complexity limit routine use of clinical risk scores in lower respiratory tract infections. Our aim was to study feasibility and effects of adding the biomarker proadrenomedullin (proADM) to the confusion, urea >7 mmol·L(−1), respiratory rate ≥30 breaths·...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrich, Werner C., Rüegger, Kristina, Dusemund, Frank, Schuetz, Philipp, Arici, Birsen, Litke, Alexander, Blum, Claudine A., Bossart, Rita, Regez, Katharina, Schild, Ursula, Guglielmetti, Merih, Conca, Antoinette, Schäfer, Petra, Schubert, Maria, de Geest, Sabina, Reutlinger, Barbara, Irani, Sarosh, Bürgi, Ulrich, Huber, Andreas, Müller, Beat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787815/
https://www.ncbi.nlm.nih.gov/pubmed/23349444
http://dx.doi.org/10.1183/09031936.00113612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787815/
https://www.ncbi.nlm.nih.gov/pubmed/23349444
http://dx.doi.org/10.1183/09031936.00113612

Ejemplares similares